I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| hepatocyte | 5 studies | 52% ± 31% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| hepatocyte | 5 studies | 52% ± 31% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 3 studies | 36% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 54230.93 | 226 / 226 | 90% | 2175.56 | 365 / 406 |
| pancreas | 98% | 227.96 | 322 / 328 | 20% | 72.66 | 36 / 178 |
| kidney | 64% | 44.70 | 57 / 89 | 1% | 3.88 | 10 / 901 |
| spleen | 49% | 90.73 | 117 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 38% | 37.03 | 352 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 37% | 3.70 | 95 / 258 | 0% | 0 | 0 / 230 |
| lung | 33% | 3.38 | 192 / 578 | 0% | 0 | 0 / 1155 |
| uterus | 32% | 3.54 | 55 / 170 | 0% | 0 | 0 / 459 |
| stomach | 31% | 2.53 | 112 / 359 | 0% | 0 | 0 / 286 |
| prostate | 30% | 2.10 | 74 / 245 | 0% | 0 | 0 / 502 |
| ovary | 29% | 2.51 | 53 / 180 | 0% | 0 | 0 / 430 |
| esophagus | 28% | 3.38 | 408 / 1445 | 0% | 0 | 0 / 183 |
| breast | 27% | 5.08 | 124 / 459 | 0% | 1.35 | 1 / 1118 |
| thymus | 25% | 2.69 | 162 / 653 | 0% | 0 | 0 / 605 |
| intestine | 24% | 2.80 | 228 / 966 | 1% | 5.19 | 4 / 527 |
| bladder | 24% | 2.52 | 5 / 21 | 0% | 0 | 0 / 504 |
| heart | 22% | 2.95 | 191 / 861 | 0% | 0 | 0 / 0 |
| skin | 22% | 2.90 | 398 / 1809 | 0% | 0 | 0 / 472 |
| blood vessel | 20% | 2.49 | 267 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 20% | 10.81 | 237 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 15% | 1.27 | 118 / 803 | 0% | 0 | 0 / 0 |
| brain | 14% | 1.16 | 377 / 2642 | 0% | 0 | 0 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0044871 | Biological process | negative regulation by host of viral glycoprotein metabolic process |
| GO_0006953 | Biological process | acute-phase response |
| GO_0061045 | Biological process | negative regulation of wound healing |
| GO_0045087 | Biological process | innate immune response |
| GO_0044869 | Biological process | negative regulation by host of viral exo-alpha-sialidase activity |
| GO_0002674 | Biological process | negative regulation of acute inflammatory response |
| GO_0046597 | Biological process | negative regulation of viral entry into host cell |
| GO_0051131 | Biological process | chaperone-mediated protein complex assembly |
| GO_0006457 | Biological process | protein folding |
| GO_1903019 | Biological process | negative regulation of glycoprotein metabolic process |
| GO_0045656 | Biological process | negative regulation of monocyte differentiation |
| GO_0048525 | Biological process | negative regulation of viral process |
| GO_1903016 | Biological process | negative regulation of exo-alpha-sialidase activity |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0072562 | Cellular component | blood microparticle |
| GO_0005634 | Cellular component | nucleus |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0051082 | Molecular function | unfolded protein binding |
| GO_0001849 | Molecular function | complement component C1q complex binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046790 | Molecular function | virion binding |
| Gene name | APCS |
| Protein name | Pentraxin family member Serum amyloid P-component (SAP) (9.5S alpha-1-glycoprotein) [Cleaved into: Serum amyloid P-component(1-203)] |
| Synonyms | hCG_39427 HEL-S-92n PTX2 |
| Description | FUNCTION: Can interact with DNA and histones and may scavenge nuclear material released from damaged circulating cells. May also function as a calcium-dependent lectin. |
| Accessions | ENST00000255040.3 V9HWP0 P02743 |
